Volume 40, Issue 3 , Pages 222-232, December 2010
A Randomized Trial of Three Psychosocial Treatments for the Symptoms of Rheumatoid Arthritis
Objective
To assess and compare the benefits of 3 psychosocial treatments for rheumatoid arthritis (RA).
Methods
RA patients were randomized to cognitive-behavior therapy (CBT), relaxation response training (RR), or arthritis education (AE). All treatment was conducted in groups. Follow-up occurred immediately after treatment and 6 and 12 months later. Pain, other RA symptoms, role impairment, and psychological distress were assessed with standardized self-report questionnaires. Arthritis severity and activity were assessed with a joint examination, erythrocyte sedimentation rate, grip strength, and walking time. An intent-to-treat analytic strategy was employed. Linear regression was used to establish treatment effect on pain and other RA symptoms, while adjusting for sociodemographic and clinical variables.
Results
One hundred sixty-eight patients were randomized. Pain improved significantly at 12 months in the RR and AE groups and showed a nonsignificant positive trend with CBT. Other RA symptoms improved significantly with CBT and AE and showed a nonsignificant trend with RR. There were no significant differences in the outcomes across the 3 treatment groups. When the results for all 3 groups were aggregated, significant benefits were found for pain, other RA symptoms, self-care activities, and social activities. Effect sizes ranged between 0.26 and 0.35.
Conclusions
These 3 psychosocial treatments were beneficial, with treatment effect sizes in the small to moderate range. The effects appeared immediately after treatment and were generally sustained at long-term follow-up. These benefits were achieved over and above those resulting from medical management. These treatments constitute an effective augmentation to standard medical therapy for RA patients.
Keywords: rheumatoid arthritis, cognitive treatment, symptoms, pain
To access this article, please choose from the options below
This work was supported by research grant R01 AR 4701401 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This study has been registered with ClinicalTrials.gov and received the identifier NCT00056667.
PII: S0049-0172(10)00052-1
doi:10.1016/j.semarthrit.2010.04.001
© 2010 Elsevier Inc. All rights reserved.
Volume 40, Issue 3 , Pages 222-232, December 2010
